Nephros Inc. NEPH
4.23
0.09
2.17%
as of 25 Sep
- Market cap
- $45.0M
- P/E
- 27.2×
Follow NEPH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 16.10% | 7.76% | 12.71% | 16.29% |
+8 more TTM periods Free account |
|
| 12.39% | 6.07% | 9.61% | 12.53% | ||
ROIC |
14.11% | 6.33% | 14.92% | 18.68% | |
Return on Tangible Assets |
16.80% | 8.56% | 13.95% | 17.72% | |
Average Days of Receivables |
72.15 | 67.20 | 46.90 | 54.17 | |
Free Cash Flow per Share |
(0.06) | (0.03) | 0.16 | 0.26 | |
Free Cash Flow |
(0.66) | (0.35) | 1.65 | 2.72 | |
Piotroski F-Score |
3.00 | 2.00 | 6.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
(3.97%) | (2.36%) | 10.54% | 17.92% | |
Accounts Receivable Turnover |
6.75 | 6.17 | 8.96 | 8.24 | |
Accounts Payable Turnover |
6.18 | 7.58 | 9.17 | 9.88 | |
Inventory Turnover |
2.37 | 2.75 | 2.45 | 2.26 | |
Average Days of Payables |
89.35 | 69.71 | 46.57 | 51.83 | |
Days of Inventory on Hand |
206.76 | 172.45 | 164.67 | 151.63 | |
Tax Rate |
(0.01) | 0.00 | 0.00 | (0.01) | |
Research and Development Expense of Revenue |
6.97% | 7.27% | 7.13% | 6.67% | |
Selling, General and Administrative Expense of Revenue |
45.77% | 48.46% | 47.90% | 47.72% | |
Share Based Compensation of Revenue |
1.30% | 1.46% | 1.58% | 1.56% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.38) | (0.45) | 1.38 | 1.84 | |
Depreciation/Fixed assets |
1.46 | 1.33 | 1.31 | 1.19 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
1.91 | 1.80 | 1.77 | 1.69 | |
Operating CF per Share |
(0.06) | (0.03) | 0.16 | 0.26 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
8.38% | 4.06% | 6.35% | 8.26% |
Columns are period end dates